Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Robert Uzzo MD, MBA, FACS

Robert G. Uzzo MD, MBA, FACS

Deputy Chief Clinical Officer and Director, Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman, Department of Surgical Oncology, Fox Chase Cancer Center; G. Willing “Wing” Pepper Professor of Urological Oncology, Fox Chase Cancer Center/Temple University; Chair, Fox Chase/Einstein Urologic Institute, Philadelphia, Pennsylvania

Dr. Uzzo graduated summa cum laude from Union College and attended Cornell University Medical College. He completed general surgical training followed by urologic surgical training at New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. He was an American Foundation for Urological Diseases Scholar in Urological Oncology and completed both Oncological and Renal Transplantation Fellowships at the Cleveland Clinic.

Dr. Uzzo is currently the Deputy Chief Clinical Officer; Director of Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman of the Department of Surgical Oncology, Fox Chase Cancer Center; and the G. Willing “Wing” Pepper Professor of Urological Oncology at Fox Chase Cancer Center/Temple University. He is also the Chair of the Fox Chase/Einstein Urologic Institute. He maintains an active, funded laboratory investigating kidney and prostate cancer. His clinical interests include minimally invasive urological oncology and renal malignancies. He has authored over 300 peer-reviewed articles in urologic oncology. 

Recent Contributions to PracticeUpdate:

  1. Prediction of Oncologic Outcomes in Patients With Small Renal Tumors
  2. Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitor Therapy for mRCC
  3. The Significance of PARP1 as a Biomarker for Response to PD-L1 Blockade in Patients With PBRM1-Mutated ccRCC
  4. Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors
  5. Active Surveillance for Risk Stratification of Small Renal Masses
  6. Positive Surgical Margin After Nephron-Sparing Surgery and Oncological Outcomes in Renal Cell Carcinoma
  7. Shared Decision–Making Tool for the Management of Small Renal Masses
  8. Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms
  9. Cryoablation vs Partial Nephrectomy for T1 Renal Tumors
  10. Predicting Intraoperative and Postoperative Consequential Events in Patients Undergoing Robot-Assisted Partial Nephrectomy

Recently Updated